Skip to content

Chuvashia Inappropriate Prescribing Study

Chuvashia Inappropriate Prescribing Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06845397
Acronym
CHIP
Enrollment
300
Registered
2025-02-25
Start date
2023-12-12
Completion date
2024-08-07
Last updated
2025-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multimorbidity, Cardiovascular Diseases

Keywords

multimorbidity, self-medication, drugs, over-the-counter (OTC) drugs, prescription drugs, adherence, inappropriate prescribing

Brief summary

This is a cross-sectional study based on an outpatient registry. All medical therapy will be registered in order to assess inappropriate prescribing's, in accordance with the criteria PROMPT and BEERS, also in accordance with the officially approved instructions for the use of this medicinal product.

Interventions

None listed

Sponsors

BU Respublikanski Kardiologicheski Dispanser Minzdrava Chuvashii, Cheboksary
CollaboratorUNKNOWN
National Medical Research Center for Therapy and Preventive Medicine
Lead SponsorOTHER_GOV

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 50 years old, multimorbidity, signed Patients' Informed Consent

Exclusion criteria

* Age \< 50 years, presence of mental illnesses, oncological diseases detected less than 5 years ago, acute cardiovascular pathology within 6 months prior to inclusion.

Design outcomes

Primary

MeasureTime frameDescription
frequency of inappropriate drug prescriptionsAssessed at baselineРrescribing medications in an inadequate dose, with the wrong frequency, and the wrong duration of treatment, failure to prescribe a potentially effective drug in the presence of clinical indications, self-medication was considered irrational treatment and was assessed as the end point. It also includes prescribing medications that are likely to have a negative effect on the course of concomitant pathology, as well as drug interactions, in accordance with the criteria PROMPT and BEERS.

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026